Shopping Cart
- Remove All
- Your shopping cart is currently empty
LMD-009 is a non-peptide, selective CCR8 agonist that mediates chemotaxis, inositol phosphate accumulation, and calcium release, with an EC50 of 11–87 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $242 | In Stock |
Description | LMD-009 is a non-peptide, selective CCR8 agonist that mediates chemotaxis, inositol phosphate accumulation, and calcium release, with an EC50 of 11–87 nM. |
Targets&IC50 | CCR8:11-87 nM (EC50) |
In vitro | Methods: COS-7 cells were treated with LMD-009 (0-20 nM, 90 minutes) and cell viability was measured. Results: LMD-009 stimulated inositol phosphate accumulation in COS-7 cells expressing the human CCR8 receptor with an EC50 value of 11 nM. It did not inhibit any other human chemokine receptors. Methods: Chinese hamster ovary cells were treated with LMD-009 (0-100 nM, 1 hour) and cell viability was measured. Results: The EC50 value of LMD-009 for regulating calcium release in Chinese hamster ovary cells was 87 nM. [1] |
Synonyms | LMD009 |
Molecular Weight | 471.59 |
Formula | C29H33N3O3 |
Cas No. | 950195-51-4 |
Smiles | O=C1NCN(CCC=2C=CC=CC2)C13CCN(CC=4C=CC=C(OC=5C=CC=CC5OC)C4)CC3 |
Relative Density. | 1.24 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 200 mg/mL (424.1 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.